BASF Partners with 3Helix to Advance Collagen-Based Solutions

Collaboration to Accelerate Development of Innovative Peptide Technologies

Monheim am Rhein, Germany - January 15, 2023

BASF, a leading global chemical company, has announced a strategic investment in 3Helix Inc., a pioneering biotechnology company specializing in collagen-based peptide solutions. This partnership aims to leverage BASF's global reach and expertise in the chemical industry with 3Helix's innovative peptide technologies, creating a powerful synergy for developing and commercializing collagen-derived products.

3Helix's proprietary technology platform enables the highly selective and efficient production of collagen-hybridizing peptides. These peptides have the ability to interact with and modify natural collagen, enhancing its functionality and properties in a variety of applications. The collaboration between BASF and 3Helix will focus on developing and optimizing these peptide solutions for industries such as cosmetics, healthcare, and food.

WEB BTC Europe GmbH, BASF's European sales organization for small and medium-sized customers focused on specialty chemicals, will play a crucial role in the distribution and commercialization of the joint solutions. As the only pan-European distributor dedicated to specialty chemicals, WEB BTC Europe offers a comprehensive network and deep market knowledge, enabling BASF and 3Helix to efficiently reach customers across Europe.

Commenting on the partnership, Dr. Markus Kamieth, President of BASF's Performance Materials business, said, "This investment in 3Helix is a testament to BASF's commitment to innovation and our vision of creating sustainable solutions for our customers. Collagen-based peptide technologies have enormous potential to transform various industries, and we believe that our collaboration with 3Helix will accelerate the development and commercialization of these revolutionary products."

Dr. Carmen Schmalbach, CEO of 3Helix, added, "We are thrilled to partner with BASF, a global leader in the chemical industry. Their extensive expertise and global reach will enable us to expand the applications of our collagen-hybridizing peptide technologies and bring innovative solutions to markets worldwide. Together, we aim to make a significant impact on the development of collagen-based products and unlock their full potential."

The collaboration between BASF and 3Helix is expected to create new opportunities for customers seeking high-performance, sustainable solutions. By combining BASF's chemical expertise with 3Helix's peptide technologies, the partnership will drive innovation and contribute to the advancement of collagen-based products.